Feeding Study in Premature Infants | Clinical Trial

Key information

Conditions

Premature Infants Female Urogenital Diseases and Pregnancy Complications Obstetric Labor Complications Obstetric Labor, Premature Pregnancy Complications Premature Birth Urogenital Diseases

Age range

Up to 40 day

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

premature infant
birth weight less than/equal to 1250 g
exclusively breast fed

Exclusion criteria

metabolic or chronic disease
major surgery
ventilator dependent

Treatment and study plan

Liquid human milk fortifier

Other

Liquid human milk fortifier added to human milk

Other names: No other names -- experimental product

Powder human milk fortifier

Other

Powder human milk fortifier added to human milk

Other names: Enfamil Human Milk Fortifier

Primary outcomes

Weight gain

Time frame: 28 days

Secondary outcomes

Feeding tolerance

Time frame: 28 days

Sponsors and collaborators

Lead sponsor

Mead Johnson Nutrition

Industry

Registry information

Important dates

Study start: 2008
Primary completion: 2010
Study completion: 2010
First posted: May 20, 2008
Registry last updated: Aug 31, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed